OTC • Last print unknown ago
$0.47—Stale · unknown old
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. specializes in the production of heparin and other active pharmaceutical ingredients (APIs), primarily serving markets in China and Europe. The company's competitive position is bolstered by its extensive manufacturing capabilities and a strong focus on R&D, which enable it to maintain a diverse product portfolio and meet stringent regulatory standards.
Hepalink generates revenue through the sale of heparin and other APIs, leveraging its cost-effective production processes and strong relationships with pharmaceutical companies. The company benefits from pricing power due to its established reputation for quality and compliance with international regulations.
Changes in heparin pricing due to global supply and demand dynamics
Regulatory approvals for new products or manufacturing facilities
Fluctuations in raw material costs impacting margins
Expansion into new international markets
Regulatory changes impacting drug approval processes
Technological disruption in pharmaceutical manufacturing
Increased competition from generic drug manufacturers
Potential entry of multinational pharmaceutical companies into the heparin market
Low return on equity (3.1%) may indicate inefficiencies in capital utilization
Potential liquidity risks if cash flow generation does not improve
moderate - the company is somewhat sensitive to economic cycles as healthcare spending can fluctuate with GDP growth, but demand for essential medications like heparin tends to remain stable.
Interest rates affect Hepalink primarily through financing costs for capital expenditures. Higher rates could increase borrowing costs, impacting profitability and expansion plans.
minimal - the company has a low debt-to-equity ratio of 0.23, indicating limited reliance on external financing.
value - the low price-to-book ratio of 1.1x suggests potential undervaluation relative to its assets.
low - the stock has shown stable performance with a 0.0% return over the past year, indicating low historical volatility.